Search research articles
Contact Us
Filters
Showing results (441-450 of 594) with videos related to
Page
of 60
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 3, 2007
Repair capacity for UV light induced DNA damage associated with risk of nonmelanoma skin cancer and tumor progression
Li-E Wang, Chunying Li, Sara S Strom, et al.
Cancer Prevention Research (Philadelphia, Pa.)
|
June 24, 2010
Epidermal growth factor receptor expression and gene copy number in the risk of oral cancer
Mohammed Taoudi Benchekroun, Pierre Saintigny, Sufi M Thomas, et al.
Molecular Cancer Therapeutics
|
October 5, 2013
Target-based therapeutic matching in early-phase clinical trials in patients with advanced colorectal cancer and PIK3CA mutations
Prasanth Ganesan, Filip Janku, Aung Naing, et al.
Journal of Immunotherapy and Precision Oncology
|
April 16, 2025
PD-L1 Testing, Treatment Patterns, and Clinical Outcomes Among Patients with Metastatic NSCLC at an Academic Medical Center, 2017-2021
Mehmet Altan, Dawen Sui, Cai Xu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 26, 2011
DNA repair biomarker profiling of head and neck cancer: Ku80 expression predicts locoregional failure and death following radiotherapy
Benjamin J Moeller, John S Yordy, Michelle D Williams, et al.
Cancer
|
April 19, 2021
Outcomes of patients with oropharyngeal squamous cell carcinoma treated with induction chemotherapy followed by concurrent chemoradiation compared with those treated with concurrent chemoradiation
Theresa W Guo, Faiez Saiyed, Christopher M K L Yao, et al.
Cancer Cell
|
November 25, 2021
The allergy mediator histamine confers resistance to immunotherapy in cancer patients via activation of the macrophage histamine receptor H1
Hongzhong Li, Yi Xiao, Qin Li, et al.
The Oncologist
|
February 28, 2026
Phase I Trial of Binimetinib Plus Hydroxychloroquine in Patients with Previously Treated Metastatic Pancreatic Cancer
S Daniel Haldar, Fen Saj, So Jung Hong, et al.
Seminars in Radiation Oncology
|
May 9, 2018
Comparing Intensity-Modulated Proton Therapy With Intensity-Modulated Photon Therapy for Oropharyngeal Cancer: The Journey From Clinical Trial Concept to Activation
Steven J Frank, Pierre Blanchard, J Jack Lee, et al.
JAMA Network Open
|
May 17, 2023
Incidence of Primary End Point Changes Among Active Cancer Phase 3 Randomized Clinical Trials
Marcus A Florez, Joseph Abi Jaoude, Roshal R Patel, et al.
Page
of 60
Search research articles
Search
Showing results (441-450 of 594) with videos related to
Sort By:
Page
of 60
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 3, 2007
Repair capacity for UV light induced DNA damage associated with risk of nonmelanoma skin cancer and tumor progression
Li-E Wang, Chunying Li, Sara S Strom, et al.
Cancer Prevention Research (Philadelphia, Pa.)
|
June 24, 2010
Epidermal growth factor receptor expression and gene copy number in the risk of oral cancer
Mohammed Taoudi Benchekroun, Pierre Saintigny, Sufi M Thomas, et al.
Molecular Cancer Therapeutics
|
October 5, 2013
Target-based therapeutic matching in early-phase clinical trials in patients with advanced colorectal cancer and PIK3CA mutations
Prasanth Ganesan, Filip Janku, Aung Naing, et al.
Journal of Immunotherapy and Precision Oncology
|
April 16, 2025
PD-L1 Testing, Treatment Patterns, and Clinical Outcomes Among Patients with Metastatic NSCLC at an Academic Medical Center, 2017-2021
Mehmet Altan, Dawen Sui, Cai Xu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 26, 2011
DNA repair biomarker profiling of head and neck cancer: Ku80 expression predicts locoregional failure and death following radiotherapy
Benjamin J Moeller, John S Yordy, Michelle D Williams, et al.
Cancer
|
April 19, 2021
Outcomes of patients with oropharyngeal squamous cell carcinoma treated with induction chemotherapy followed by concurrent chemoradiation compared with those treated with concurrent chemoradiation
Theresa W Guo, Faiez Saiyed, Christopher M K L Yao, et al.
Cancer Cell
|
November 25, 2021
The allergy mediator histamine confers resistance to immunotherapy in cancer patients via activation of the macrophage histamine receptor H1
Hongzhong Li, Yi Xiao, Qin Li, et al.
The Oncologist
|
February 28, 2026
Phase I Trial of Binimetinib Plus Hydroxychloroquine in Patients with Previously Treated Metastatic Pancreatic Cancer
S Daniel Haldar, Fen Saj, So Jung Hong, et al.
Seminars in Radiation Oncology
|
May 9, 2018
Comparing Intensity-Modulated Proton Therapy With Intensity-Modulated Photon Therapy for Oropharyngeal Cancer: The Journey From Clinical Trial Concept to Activation
Steven J Frank, Pierre Blanchard, J Jack Lee, et al.
JAMA Network Open
|
May 17, 2023
Incidence of Primary End Point Changes Among Active Cancer Phase 3 Randomized Clinical Trials
Marcus A Florez, Joseph Abi Jaoude, Roshal R Patel, et al.
Page
of 60